Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1981 |
100 Clinical Results associated with Lishui University
0 Patents (Medical) associated with Lishui University
100 Deals associated with Lishui University
100 Translational Medicine associated with Lishui University